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In this presentation, two aspects concerning the immunopathology of tuberculosis
at the microanatomical level will be considered. The material for this presentation is
drawn from our studies on tuberculous lymphadenitis (450 cases) and skin tuberculosis
(270 cases).
The first question to be considered is ‘when is it necessary to demonstrate the
components of M.tuberculosis in the tissues?’ The second is the question of the
involvement of humoral immune factors associated with some of the histological
manifestations of tuberculosis.
Demonstration of the components Of M. tuberculosis
There are three clinical situations where it is necessary to visualise the
components (either as antigens or as nucleic acids) of M.tuberculosis in the affected
tissues.
1. Establishment of Diagnosis
Histopathologically, the signature of tuberculosis is usually unmistakable. The
usual picture of a well-formed, epithelioid cell, giant cell, lymphocyte, plasma cell
granuloma with a central caseation necrosis is often enough to confirm the clinical
diagnosis of tuberculosis in an endemic country.
However, in about 25% of the cases, variant forms may be seen. These may
include a well-formed, non necrotic, epithelioid cell granuloma at one end and a poorly-
organised granuloma with vacuolated macrophage and necrosis without caseation at the
other end. In such cases, demonstration of bacilli either by Ziehl-Neelson (Z-N) staining
or culture for M tuberculosis would be helpful in establishing the diagnosis. Nevertheless,
in about 40% of these cases, bacilli are usually not seen using Z-N staining and 25% of
these are culture negative for M. tuberculosis. It is likely that demonstration of the
bacillary components in such cases using probes which are specific for the organism will
help the pathologist to arrive at the diagnosis of tuberculosis in such atypical
presentations.
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2. Establishment of the aetiology of granulomatous inflammation:
Identification of the nucleic acids of M. tuberculosis in granulomatous lesions has
helped to identify the aetiological agent in two conditions.
a. Tuberculids: Erythema induratum and papulonecrotic tuberculids occurring
in the skin are rare conditions traditionally attributed to a tuberculous aetiology. A
casealing granuloma is often seen histologically and this has been considered to be a
manifestation of tubcrculous hypersensitivity with the primary lodgement of the bacilli
elsewhere in the body as M. tuberculosis cannot be cultured from these lesions.
Recently, the tuberculous aeliology of these lesions has been confirmed by Degitz
and his colleagues (1993). Using a 383bp fragment of the mycobacterial gro EL gene
amplified by primers TB1 and TB2, the tuberculous actiology of this granulomatous lesion
has been identified by these workers.
b.Sarcoidosis: This forms an important differential diagnosis both clinically and
histologically while a diagnosis of tuberculosis is actively considered. The aetiology of
this condition has long remained a matter of speculation. However, several investigators
have demonstrated M. tuberculosis nucleic acids in these lesions (reviewed in Mangiapan
and Hance, 1995). It is possible that the granulomatous inflammation in sarcoidosis is an
allergic manifestation caused by fragmented M. tuberculosis.
3. Establishment of resolution
Demonstration of the presence of M. tuberculosis antigen(s) may be of use in one
more clinical situation. It is sometimes seen that in patients with tuberculous
lymphadenitis. the lymph node does not decrease in size completely after a full course of
anti tuberculous therapy (ATT). In such situations, biopsy of the node has shown that
while a residual granuloma is still present, M. tuberculosis is neither seen on ZN staining
nor can it be cultured. Demonstration of M. tuberculosis antigen will be of use in deciding
whether the granuloma is still active and therefore require a further course of ATT.
Experiments were therefore conducted in the guinea pig to observe the resolution
of granuloma vis a vis intact bacilli and M. tuberculosis antigen. Killed M. tuberculosis
(2 X 107) was injected intradermally and groups of four animals were sacrificed at various
time points from 611 to 12 weeks and the injected site was removed. In another
experiment, live M. tubercu1osis (2 X 107) was injected intramuscularly and the animals
were sacrificed from 4 to 44 weeks and their spleen, liver and lung were obtained. These,
along with the skin specimens were evaluated for the presence of granuloma, acid fast
bacilli (AFB) and M. tuberculosis antigen(s). Tuberculous antigen was demonstrated using
polyclonal anti M. tuberculosis antiserum in an indirect immunoperoxidase method.
In all the four organs sites examined, stainable bacilli were the first to disappear
followed by M. tuberculosis antigen and finally only the granuloma resolved. Further, it
was found that the splenic culture of the infected guinea pig for M. tuberculosis became
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negative long before the disappearence of the antigen. It is therefore concluded that the
presence of granuloma in the absence of antigen in a clinical specimen from a residual
lesion probably indicates that the granuloma is in the resolving stage and that the patient
may not require further ATT.
Whither R cell responses in tuberculous granuloma?
A detailed analysis of the cellular profile of the histology of tuberculous
lymphadenitis (TBL) and cutaneous tuberculosis (CTB) revealed the following:
1. A spectrum of responses varying from a well-organised, non necrotic epithelioid
cell granuloma (Hyperplastic) through a caseating, epithelioid cell granuloma
(Reactive) to a poorly-organised, macrophage granuloma with noncaseating
necrosis (Hyporeactive and Nonreactive) was observed.
2. In cutaneous tuberculosis, the histology correlates with the clinical spectrum of
venucosa cutis, lupus vulgaris and scrofuloderma. Verrucosa cutis is
characterised by a non necrotic, epithelioid cell granuloma while in
scrofuloderma, necrosis is a hall mark of its histology. In lupus vulgaris,
minimal necrosis was seen in 9 out of 127 cases.
3. Plasma cells and B cells were found in moderate numbers in all these
granulomata; these were seen more often when there was necrosis (Table 1).
4. There were no differences in the response to purified protein derivative (RT23)
at 72 hours amongst the various histological groups within TBL or within CTB
(Table 2).
TABLE 1: DISTRIBUTION OF PLASMA CELLS AND B LXMPHOCYTES IN
TUBERCULOUS LYMPHADENITIS AND SKIN TUBERCULOSIS
(Mean±95% confidence interval)
TYPE PLASMA CELLS B LXMPHOCYTES
LYMPH NODE
HYPERPLASTIC 0.7±0.3 6.8±1.2
12.1±0.9
18.5±5.8 19.4±1.5
REACTIVE
HXPO REACTIVE
NON REACTIVE
SKIN
LUPUS VULGARIS
VERRUCOSA CUTIS
SCROFULODERMA
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TABLE 2: MANTOUX REACTION AT 48h TO PPD
TYPE <1Omm > 1 O m m  M E A N 95% C.I.
LYMPH NODE
HYPERPLASTIC 9 55 25.5 20.8-28.3
REACTIVE 24 135 26.8 24.1-29.5
HYPOREACTIVE 8 41 25.4 22.8-27.9
NONREACTIVE 4 7 27.3 15.2-34.3
LUPUS VULGARIS 11 72 16.9 14.9-18.9
VERRUCOSA CUTIS 11 61 17.9 15.7-20.1
SCROFULODERMA 2 17 19.2 15.4-23-0
It is possible that these represent a polarisation of the T lymphocyte responses
into Type 1 and Type 2 patterns as has been demonstrated in leprosy lesions (Yamamura
et al, 1991; Salgame et al, 1991). The patterns of T cell cytokine response from human
peripheral blood mononuclear cells to PPD have been studied (Del Prete et al, 1991;
Barnes et al, 1992). A shift from Thl to Th2 response occurs when the acute stage of’ the
disease leads onto the chronic stage in the lung tissue of a murine model for tuberculosis
(Hemandez-Pondo et al, 1996).
The cytokine profile of the lymphocytes in human tuberculous granuloma is yet
to be characterised fully. It is tempting to argue that the histological spectrum observed
in TBL and CTB may represent polariscd T cell responses. However, the Mantoux
reactions in these patients do not show differences amongst the various histological groups
suggesting that a clear cut polarisation as seen in leprosy lesions may not be demonstrable
in tuberculosis though this needs to be looked at in greater detail.
The presence of moderate numbers of B cells and plasma cells in lesions where
there is necrosis needs to be explored further. A number of possibilities exist to explain
their presence and some of them are discussed here.
The plasma cells arising from B cells can produce antibodies and along with the
fragmented M. tuberculosis antigen can form in situ immune complexes. These then can
not only initiate but also determine the type of granuloma formed (Spector and Heesom,
1969; Ridley et al. 1982). Futher, Campa et al (1989). have shown that anti idiotypic B
cells against M. tuberculosis can modulate both granuloma formation and delayed
hypersensitivity reaction to PPD. Antigen-specific B lymphocytes are potent antigen
presenting cells. It is known that B cells presenting antigen to naive T lymphocyte can
result in tolerance whereas if they present antigen to sensitized T cells, they can be
immunized (reviewed in Matzinger, 1994).
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Recommendations
In view of the foregoing. three major areas of research concerning the
immunopathology of tuberculosis are recommended.
Development of reagents to identify M. tuberculosis antigen(s)/nucleic acid(s) in
tissues suspected to be of tuberculous pathology though with a caveat. It is
advisable to use these reagents only when there is a prima facie case for doing
so. In other words, the lesion should have a granuloma and bacilli not
demonstrable either using Z-N staining or by culture for the organism.
Delineation of the in situ cytokine responses in different histological forms of
tuberculosis.
Elucidation of the role of humoral immune responses, especially that of the B
lymphocytes in the histological manifestations of the disease.
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